HCL Applied sciences Ltd’s traders are upbeat, particularly in a world the place international macroeconomic gloom has currently saved IT shares on tenterhooks. HCL’s shares surged virtually 8% on Wednesday following its March quarter (Q4FY25) outcomes. Sequentially, the corporate’s income dropped 0.8% in fixed foreign money (CC) phrases final quarter, in comparison with the consensus estimate of a 0.5% income drop, harm by the same old seasonality in its software program enterprise.
Nonetheless, the Avenue appears to have derived optimism from HCL’s FY26 steering and sturdy deal wins.
The corporate foresees year-on-year income progress of 2-5% in CC phrases, for each consolidated and providers enterprise. Whereas the steering is modest, it’s higher than rivals Infosys Ltd and Wipro Ltd. “HCL’s FY26 income progress steering was barely higher than expectations, in addition to Infosys (0%–3%), with affordable required compound quarterly progress charge (0.3%–1.5%),” mentioned Nuvama Analysis.
Learn this | Massive 4 of Indian IT lose market share; HCL Tech’s outlook affords little aid
The steering consists of round 100 foundation factors of inorganic contribution.
The decrease finish of the vary assumes deterioration in macros, weighing on giant deal closures in Q1FY26. The highest-end assumes a steady macro surroundings, the place sturdy Q4FY25 bookings proceed to ramp up, and enormous offers shut efficiently in Q1FY26.
HCL acknowledges that the demand surroundings stays difficult. Macroeconomic headwinds, together with tariff hikes and de-globalization, are seen impacting decision-making cycles. Due to this fact, the administration stays cautious on retail, auto (tariff-sensitive sectors), and discretionary segments. Nonetheless, power, BFSI, and digital infrastructure are higher positioned. Standard seasonality is predicted in Q1FY26, however sequential income progress within the quarter wouldn’t be as weak as Q1FY25, it added.
HCL secured new offers price a complete contract worth of roughly $3 billion in Q4FY25, bolstered by a mega deal, up from $2.1 billion in Q3FY25. This brings the overall for FY25 to $9.4 billion. The deal pipeline stays sturdy, with near-record ranges, and synthetic intelligence (AI) and generative AI are integral elements of most offers within the pipeline, it mentioned. Each the Americas and the EU have seen appreciable progress within the deal pipeline.
Total, earnings earlier than curiosity and tax (Ebit) margin declined sequentially to 18%, impacted by the second cycle of wage increments, product seasonality and better bills, partly offset by working efficiencies and foreign exchange actions. The corporate maintained its Ebit margin steering for FY26 at 18-19%.
Learn this | What feeble order books foretell for India’s tech bluechips
PL Capital anticipates additional contribution from HCL’s high-margin merchandise and platforms (P&P) enterprise to FY26 margins, because the broking agency expects the section to get better this 12 months by way of increasing alternatives in rising markets. Notably, FY25 noticed P&P enterprise progress of three.5% year-on-year in fixed foreign money phrases, up from 2.3% in FY24 and 1.8% in FY23.
Nonetheless, that wasn’t sufficient to forestall earnings downgrades. Whereas administration highlighted a 75% year-on-year soar in FY25 ER&D bookings, the discretionary nature of those offers raises the chance of execution delays—probably weighing on HCL’s natural progress prospects in FY26.
In a report dated 22 April, Kotak Institutional Equities famous that HCL had benefited from mega deal ramps over the previous two years however now wants extra momentum to maintain sturdy progress. The brokerage has minimize its FY25–27 earnings per share (EPS) estimates by about 2–5%.
Nomura Analysis has additionally minimize its FY26-27F EPS by about 2% and goal worth from ₹1,840 (based mostly on 25x FY27F EPS) to ₹1,670 (23x FY27F EPS), acknowledging rising macro uncertainty dangers.
Additionally learn | Mayhem for IT shares as FIIs pull out huge. What lies forward?
Regardless of Wednesday’s good points, HCL’s shares are down about 20% from the 52-week excessive of ₹2,012.20 apiece seen on 13 January. Valuations are usually not comforting, nevertheless. At FY26 price-to-earnings, it’s buying and selling at a number of of 23x, confirmed Bloomberg knowledge. It is a slight premium to Infosys Ltd and virtually on a par with Tata Consultancy Providers Ltd, leaving little room for error.
